Insider · CIK 0001276039

TALLARIGO LORENZO

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001276039

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-07-07	INTERCEPT PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,000 sh	$242.11	−$242K	1,000
2014-07-07	INTERCEPT PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,000 sh	$244.00	−$244K	0
2014-07-07	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$9.82	+$19.6K	2,000
2014-07-07	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	4,923
2014-02-10	INTERCEPT PHARMACEUTICALS, INC.S Sale	Director	SSale	−368 sh	$354.52	−$130K	1,640
2014-02-09	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+368 sh	—	—	2,008
2014-02-09	INTERCEPT PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−368 sh	—	—	735
2014-01-07	INTERCEPT PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,839 sh	$67.41	−$124K	1,640
2013-11-09	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+368 sh	—	—	3,479
2013-11-09	INTERCEPT PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−368 sh	—	—	1,103
2013-10-21	INTERCEPT PHARMACEUTICALS, INC.S Sale	Director	SSale	−125K sh	$62.50	−$7.81M	5,938,890
2013-10-15	INTERCEPT PHARMACEUTICALS, INC.S Sale	Director	SSale	−1.12M sh	$62.50	−$70.2M	6,063,802
2013-10-10	INTERCEPT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,471 sh	—	—	3,111
2013-10-10	INTERCEPT PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,471 sh	—	—	1,471
2013-05-07	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+1,640 sh	—	—	1,640
2013-05-07	INTERCEPT PHARMACEUTICALS, INC.Options to Purchase Common StockA Award	Director	AAward	+2,450 sh	—	—	2,450
2012-11-16	INTERCEPT PHARMACEUTICALS, INC.Restricted Stock UnitsA Award	Director	AAward	+2,942 sh	—	—	2,942
2012-11-16	INTERCEPT PHARMACEUTICALS, INC.Options to Purchase Common StockA Award	Director	AAward	+4,673 sh	—	—	4,673
2012-10-16	INTERCEPT PHARMACEUTICALS, INC.C Conversion	Director	CConversion	+2.4M sh	—	—	4,004,537
2012-10-16	INTERCEPT PHARMACEUTICALS, INC.C Conversion	Director	CConversion	+2.4M sh	—	—	6,408,374
2012-10-16	INTERCEPT PHARMACEUTICALS, INC.C Conversion	Director	CConversion	+779K sh	—	—	7,187,217
2012-10-16	INTERCEPT PHARMACEUTICALS, INC.Series A Preferred StockC Conversion	Director	CConversion	−13.9M sh	—	—	0
2012-10-16	INTERCEPT PHARMACEUTICALS, INC.Series B Preferred StockC Conversion	Director	CConversion	−13.9M sh	—	—	0
2012-10-16	INTERCEPT PHARMACEUTICALS, INC.Series C Preferred StockC Conversion	Director	CConversion	−4.5M sh	—	—	0
2012-08-09	INTERCEPT PHARMACEUTICALS, INC.Series C Preferred StockP Purchase	Director	PPurchase	+4.5M sh	$2.00	+$9M	4,500,000
2012-07-31	INTERCEPT PHARMACEUTICALS, INC.Options to Purchase Common StockA Award	Director	AAward	+4,326 sh	—	—	4,326
2008-03-24	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−2,043 sh	$49.84	−$102K	74,062
2008-02-01	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−6,304 sh	$51.52	−$325K	86,105
2007-11-30	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−1,626 sh	$52.79	−$85.8K	68,899
2007-06-01	LLYELI LILLY & CoS Sale	President, Internat'l Opers.	SSale	−4,533 sh	$58.73	−$266K	75,058
2007-02-01	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−4,214 sh	$54.12	−$228K	84,124
2006-07-14	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−1,543 sh	$54.88	−$84.7K	66,127
2005-07-01	LLYELI LILLY & CoM Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	+2,000 sh	$23.41	+$46.8K	58,715
2005-07-01	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−1,199 sh	$55.71	−$66.8K	57,516
2005-07-01	LLYELI LILLY & Co · Employee stock option 10/95 (right to buy)M Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	−2,000 sh	—	—	0
2005-06-01	LLYELI LILLY & CoM Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	+2,000 sh	$23.41	+$46.8K	57,889
2005-06-01	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−1,174 sh	$58.30	−$68.4K	56,715
2005-06-01	LLYELI LILLY & Co · Employee stock option 10/95 (right to buy)M Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	−2,000 sh	—	—	2,000
2005-05-02	LLYELI LILLY & CoM Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	+2,000 sh	$23.41	+$46.8K	57,060
2005-05-02	LLYELI LILLY & CoF Tax Payment	President, Internat'l Opers.	FTax Payment	−1,171 sh	$58.47	−$68.5K	55,889
2005-05-02	LLYELI LILLY & Co · Employee stock option 10/95 (right to buy)M Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	−2,000 sh	—	—	4,000
2005-02-11	LLYELI LILLY & Co · Employee stock option (right to buy)A Award	President, Internat'l Opers.	AAward	+53.3K sh	—	—	53,254
2005-02-03	LLYELI LILLY & CoM Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	+2,000 sh	$23.41	+$46.8K	56,299.36
2005-02-03	LLYELI LILLY & Co · Employee stock option (right to buy)M Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	−2,000 sh	—	—	10,000
2005-01-14	LLYELI LILLY & CoA Award	President, Internat'l Opers.	AAward	+5,600 sh	$56.79	+$318K	54,299.36
2004-12-20	LLYELI LILLY & CoA Award	President, Internat'l Opers.	AAward	+15K sh	—	—	48,699.36
2004-10-14	LLYELI LILLY & CoM Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	+12K sh	$14.66	+$176K	33,699.36
2004-10-14	LLYELI LILLY & Co · Employee stock option (right to buy)M Exercise/Conversion	President, Internat'l Opers.	MExercise/Conversion	−12K sh	—	—	0

Recent filings

Accepted (ET)
Jul 94
INTERCEPT PHARMACEUTICALS INC0001144204-14-042176
SEC(opens sec.gov)
Feb 114
INTERCEPT PHARMACEUTICALS INC0001144204-14-007725
SEC(opens sec.gov)
Jan 94
INTERCEPT PHARMACEUTICALS INC0001144204-14-001504
SEC(opens sec.gov)
Nov 124
INTERCEPT PHARMACEUTICALS INC0001144204-13-060692
SEC(opens sec.gov)
Oct 234
INTERCEPT PHARMACEUTICALS INC0001144204-13-056563
SEC(opens sec.gov)
Oct 174
INTERCEPT PHARMACEUTICALS INC0001144204-13-055680
SEC(opens sec.gov)
Oct 114
INTERCEPT PHARMACEUTICALS INC0001144204-13-055020
SEC(opens sec.gov)
May 94
INTERCEPT PHARMACEUTICALS INC0001144204-13-027623
SEC(opens sec.gov)
Nov 204
TALLARIGO LORENZO0001144204-12-064361
SEC(opens sec.gov)
Oct 164
TALLARIGO LORENZO0001144204-12-056462
SEC(opens sec.gov)

Companies

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET

NEW YORK, NY, 10013